Healing Hearts - Saving Lives

The only transcatheter solution that combines repair and replacement for the Mitral valve in one procedure

The

Opportunity

Globally there are more than 15 million Mitral Regurgitation (MR) patients;

4.5 million are suffering from severe MR

The treatments currently available for severe MR patients with heart failure are limited. Surgical repair and replacement are not possible for 98% of patients

Mortality and morbidity are high among untreated patients with mortality at 1-year up to 57%

The

Solution

VALFIX has developed an innovative transcatheter system to treat patients suffering from severe Mitral Regurgitation and Heart-Failure.

The unique and innovative multi-wire technology enables transcatheter Mitral valve repair and replacement in one procedure. 

VALFIX offers a true transcatheter complete ring annuloplasty procedure which is considered first-line therapy and the gold standard in Mitral surgery.